From MarketBeat:

Danaher Stock Upgrade:
Danaher (NYSE:DHR) was upgraded by StockNews.com from a “hold” rating to a “buy” rating. Other analysts also recently issued reports, with an average rating of “Moderate Buy” and an average price target of $259.40.

Danaher Stock Performance:
Danaher stock opened at $227.96. The firm has a market cap of $168.45 billion and a PE ratio of 28.75. The company reported $2.02 EPS for the last quarter and is projected to post 8.31 earnings per share for the current year.

Institutional Inflows and Outflows:
Several hedge funds have increased their holdings in Danaher, with institutional investors owning 76.71% of the company’s stock.

Danaher Company Profile:
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; and healthcare filtration solutions.



Read more: Danaher (NYSE:DHR) Lifted to “Buy” at StockNews.com